Omada Health

Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight
Xtalks
Fri, 11/15/24 - 11:27 am
Omada Health
GLP-1 agonists
obesity
weight loss
Novo Nordisk
Eli Lilly
Ozempic
Zepbound
Mounjaro
Wegovy
Omada Health launches new programs for obesity-related diseases
Healthcare Dive
Fri, 06/22/18 - 07:52 pm
Omada Health
digital therapeutics
hypertension
diabetes
obesity